Publication Cover
Canadian Journal of Pain
Revue canadienne de la douleur
Volume 4, 2020 - Issue 1
7,408
Views
7
CrossRef citations to date
0
Altmetric
Case Report

Association of small-fiber polyneuropathy with three previously unassociated rare missense SCN9A variants

&
Pages 19-29 | Received 05 Nov 2019, Accepted 01 Jan 2020, Published online: 05 Feb 2020

References

  • Oaklander AL, Nolano M. Scientific advances in and clinical approaches to small-fiber polyneuropathy: a review. JAMA Neurol. 2019;76(10):1240–51. doi:10.1001/jamaneurol.2019.2917.
  • Albrecht PJ, Hou Q, Argoff CE, Storey JR, Wymer JP, Rice FL. Excessive peptidergic sensory innervation of cutaneous arteriole-venule shunts (AVS) in the palmar glabrous skin of fibromyalgia patients: implications for widespread deep tissue pain and fatigue. Pain Med. 2013;14(6):895–915. doi:10.1111/pme.12139.
  • Fukuda T, Takeda S, Xu R, Ochi, H, Sunamura, S, Sato, T, Shibata, S, Yoshida, Y, Gu, Z, Kimura, A, et al. Sema3A regulates bone-mass accrual through sensory innervations. Nature. 2013;497(7450):490–93. doi:10.1038/nature12115.
  • Steinhoff M, Schmelz M, Szabo IL, Oaklander AL. Clinical presentation, management, and pathophysiology of neuropathic itch. Lancet Neurol. 2018;17(8):709–20. doi:10.1016/S1474-4422(18)30217-5.
  • Thieben MJ, Sandroni P, Sletten DM, Benrud-Larson, LM, Fealey, RD, Vernino, S, Low, PA, Lennon, VA, et al. Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc. 2007;82(3):308–13. doi:10.1016/S0025-6196(11)61027-6.
  • Treister R, Lodahl M, Lang M, Tworoger SS, Sawilowsky S, Oaklander AL. Initial development and validation of a patient-reported symptom survey for small-fiber polyneuropathy. J Pain. 2017;18(5):556–63. doi:10.1016/j.jpain.2016.12.014.
  • Amato AA, Oaklander AL. Case records of the Massachusetts general hospital. Weekly clinicopathological exercises. Case 16–2004. A 76-year-old woman with numbness and pain in the feet and legs. N Engl J Med. 2004;350(21):2181–89. doi:10.1056/NEJMcpc049005.
  • Gewandter JS, Freeman R, Dworkin R, et al. Diagnostic criteria for idiopathic distal sensory polyneuropathy and small-fiber polyneuropathy. Paper presented at: 2020 Conference of the American Academy of Neurology; 2020; Toronto, CA.
  • England JD, Gronseth GS, Franklin G, Carter, GT, Kinsella, LJ, Cohen, JA, Asbury, AK, Szigeti, K, Lupski, JR,Latov, N, et al. Practice parameter: evaluation of distal symmetric polyneuropathy: role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology. 2009;72(2):177–84. doi:10.1212/01.wnl.0000336345.70511.0f.
  • Lauria G, Hsieh ST, Johansson O, Kennedy, WR, Leger, JM, Mellgren, SI, Nolano, M, Merkies, IS, Polydefkis, M, Smith, AG, et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol. 2010;17(7):903–912, e944–909. doi:10.1111/j.1468-1331.2010.03023.x.
  • Thompson RJ, Doran JF, Jackson P, Dhillon AP, Rode J. PGP9.5: a new marker for vertebrate neurons and neuroendocrine cells. Brain Res. 1983;278:224–28. doi:10.1016/0006-8993(83)90241-X.
  • Sommer C. Nerve and skin biopsy in neuropathies. Curr Opin Neurol. 2018;31(5):534–40. doi:10.1097/WCO.0000000000000601.
  • Provitera V, Gibbons CH, Wendelschafer-Crabb G, Donadio, V, Vitale, DF, Loavenbruck, A, Stancanelli, A, Caporaso, G, Liguori, R, Wang, N, et al. The role of skin biopsy in differentiating small-fiber neuropathy from ganglionopathy. Eur J Neurol. 2018;25(6):848–53. doi:10.1111/ene.13608.
  • Hoffman EM, Staff NP, Robb JM, St Sauver JL, Dyck PJ, Klein CJ. Impairments and comorbidities of polyneuropathy revealed by population-based analyses. Neurology. 2015;84(16):1644–51. doi:10.1212/WNL.0000000000001492.
  • Visser NA, Notermans NC, Linssen RS, van den Berg LH, Vrancken AF. Incidence of polyneuropathy in Utrecht, the Netherlands. Neurology. 2015;84(3):259–64. doi:10.1212/WNL.0000000000001160.
  • Peters MJ, Bakkers M, Merkies IS, Hoeijmakers JG, van Raak EP, Faber CG. Incidence and prevalence of small-fiber neuropathy: a survey in the Netherlands. Neurology. 2013;81(15):1356–60. doi:10.1212/WNL.0b013e3182a8236e.
  • Farhad K, Traub R, Ruzhansky KM, Brannagan TH 3rd. Causes of neuropathy in patients referred as “idiopathic neuropathy”. Muscle Nerve. 2016;53(6):856–61. doi:10.1002/mus.24969.
  • Gallagher G, Rabquer A, Kerber K, Calabek B, Callaghan B. Value of thyroid and rheumatologic studies in the evaluation of peripheral neuropathy. Neurol. 2013;3(2):90–98. doi:10.1212/CPJ.0b013e31828d9f2c.
  • Lang M, Treister R, Oaklander AL. Diagnostic value of blood tests for occult causes of initially idiopathic small-fiber polyneuropathy. J Neurol. 2016;263(12):2515–27. doi:10.1007/s00415-016-8270-5.
  • de Greef BTA, Hoeijmakers JGJ, Gorissen-Brouwers CML, Geerts M, Faber CG, Merkies ISJ. Associated conditions in small fiber neuropathy - a large cohort study and review of the literature. Eur J Neurol. 2018;25(2):348–55. doi:10.1111/ene.13508.
  • Lefaucheur JP, Sène D, Oaklander AL. Primary Sjögren’s syndrome. N Engl J Med. 2018;379:96.
  • Gaillet A, Champion K, Lefaucheur J, Trout H, Bergmann J, Sène D. Intravenous immunoglobulin efficacy for primary Sjögren’s syndrome associated small fiber neuropathy. Autoimmun Rev. 2019. doi:10.1016/j.autrev.2019.102387.
  • Suarez GA, Fealey RD, Camilleri M, Low PA. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology. 1994;44(9):1675–82. doi:10.1212/WNL.44.9.1675.
  • Watari M, Nakane S, Mukaino A, Nakajima, M, Mori, Y, Maeda, Y, Masuda, T, Takamatsu, K, Kouzaki, Y, Higuchi, O, et al. Autoimmune postural orthostatic tachycardia syndrome. Ann Clin Transl Neurol. 2018;5(4):486–92. doi:10.1002/acn3.524.
  • Yuki N, Chan AC, Wong AHY, Inoue, T, Yokai, M, Kurihara, T, Devaux, JJ, Wilder‐Smith, E Acute painful autoimmune neuropathy: a variant of Guillain-Barré syndrome. Muscle Nerve. 2017.
  • Oaklander AL, Klein MM. Evidence of small-fiber polyneuropathy in unexplained, juvenile-onset, widespread pain syndromes. Pediatrics. 2013;131(4):e1091–e1100. doi:10.1542/peds.2012-2597.
  • Liu X, Treister R, Lang M, Oaklander AL. IVIg for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety. Ther Adv Neurol Disord. 2018;11:1756285617744484. doi:10.1177/1756285617744484.
  • Schofield JR, Chemali KR. Intravenous immunoglobulin therapy in refractory autoimmune dysautonomias: a retrospective analysis of 38 patients. Am J Ther. 2018;26:e570–e582.
  • Skerratt SE, West CW. Ion channel therapeutics for pain. Channels (Austin). 2015;9(6):344–51. doi:10.1080/19336950.2015.1075105.
  • Waxman SG, Zamponi GW. Regulating excitability of peripheral afferents: emerging ion channel targets. Nat Neurosci. 2014;17(2):153–63. doi:10.1038/nn.3602.
  • Cox JJ, Reimann F, Nicholas AK, Thornton, G, Roberts, E, Springell, K, Karbani, G, Jafri, H, Mannan, J, Raashid, Y, et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature. 2006;444(7121):894–98. doi:10.1038/nature05413.
  • Hoffmann T, Sharon O, Wittmann J, Carr, RW, Vyshnevska, A, De Col, R, Nassar, MA, Reeh, PW, Weidner, C. NaV1.7 and pain: contribution of peripheral nerves. Pain. 2018;159(3):496–506. doi:10.1097/j.pain.0000000000001119.
  • Brouwer BA, Merkies IS, Gerrits MM, Waxman SG, Hoeijmakers JG, Faber CG. Painful neuropathies: the emerging role of sodium channelopathies. J Peripher Nerv Syst. 2014;19(2):53–65. doi:10.1111/jns5.2014.19.issue-2.
  • Kapetis D, Sassone J, Yang Y, Galbardi, B, Xenakis, MN, Westra, RL, Szklarczyk, R, Lindsey, P, Faber, CG, Gerrits, M, et al. Network topology of NaV1.7 mutations in sodium channel-related painful disorders. Syst Biol BMC. 2017;11(1):28.
  • Dabby R, Sadeh M, Broitman Y, Yosovich K, Dickman R, Leshinsky-Silver E. Painful small fiber neuropathy with gastroparesis: a new phenotype with a novel mutation in the SCN10A gene. J Clin Neurosci. 2016;26:84–88. doi:10.1016/j.jocn.2015.05.071.
  • Bennett DL, Woods CG. Painful and painless channelopathies. Lancet Neurol. 2014;13:587–99. doi:10.1016/S1474-4422(14)70024-9.
  • Wadhawan S, Pant S, Golhar R, Kirov, S, Thompson, J, Jacobsen, L, Qureshi, I, Ajroud-Driss, S, Freeman, R, Simpson, DM, et al. NaV channel variants in patients with painful and nonpainful peripheral neuropathy. Neurol Genet. 2017;3(6):e207. doi:10.1212/NXG.0000000000000207.
  • Eijkenboom I, Sopacua M, Hoeijmakers JGJ, De Greef, BT, Lindsey, P, Almomani, R, Marchi, M, Vanoevelen, J, Smeets, HJ, Waxman, SG, et al. Yield of peripheral sodium channels gene screening in pure small fibre neuropathy. J Neurol Neurosurg Psychiatry. 2019;90(3):342–52. doi:10.1136/jnnp-2018-319042.
  • Staff NP, Engelstad J, Klein CJ, Amrami, KK, Spinner, RJ, Dyck, PJ, Warner, MA, Warner, ME, et al. Post-surgical inflammatory neuropathy. Brain. 2010;133(10):2866–80. doi:10.1093/brain/awq252.
  • Lunn MP, Ellis L, Hadden RD, Rajabally YA, Winer JB, Reilly MM. A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies. J Peripher Nerv Syst. 2016;21(1):33–37. doi:10.1111/jns.2016.21.issue-1.
  • Faber CG, Hoeijmakers JGJ, Ahn HS, Cheng, X, Han, C, Choi, JS, Estacion, M, Lauria, G, Vanhoutte, EK, Gerrits, MM, et al. Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol. 2012;71(1):26–39. doi:10.1002/ana.22485.
  • Genomes Project Consortium, Abecasis GR, Altshuler D, et al. A map of human genome variation from population-scale sequencing. Nature. 2010;467(7319):1061–73. doi:10.1038/nature09534.
  • Kang SK, Vanoye CG, Misra SN, Echevarria, DM, Calhoun, JD, O’Connor, JB, Fabre, KL, McKnight, D, Demmer, L, Goldenberg, P, et al. Spectrum of KV 2.1 dysfunction in KCNB1-associated neurodevelopmental disorders. Ann Neurol. 2019;86(6):899–912. doi:10.1002/ana.25607.
  • Manrai AK, Funke BH, Rehm HL, Olesen, MS, Maron, BA, Szolovits, P, Margulies, DM, Loscalzo, J, et al. Genetic misdiagnoses and the potential for health disparities. N Engl J Med. 2016;375(7):655–65. doi:10.1056/NEJMsa1507092.
  • Stock W, Diouf B, Crews KR, Pei, D, Cheng, C, Laumann, K, Mandrekar, SJ, Luger, S, Advani, A, Stone, RM, et al. An inherited genetic variant in CEP72 promoter predisposes to vincristine-induced peripheral neuropathy in adults with acute lymphoblastic leukemia. Clin Pharmacol Ther. 2016;101:391–95.
  • Beutler AS, Kulkarni AA, Kanwar R, Klein, CJ, Therneau, TM, Qin, R, Banck, MS, Boora, GK, Ruddy, KJ, Wu, Y, et al. Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy. Ann Neurol. 2014;76(5):727–37. doi:10.1002/ana.24265.
  • Tomaselli PJ, Rossor AM, Horga A, Jaunmuktane, Z, Carr, A, Saveri, P, Piscosquito, G, Pareyson, D, Laura, M, Blake, JC, et al. Mutations in noncoding regions of GJB1 are a major cause of X-linked CMT. Neurology. 2017;88(15):1445–53. doi:10.1212/WNL.0000000000003819.
  • Pipis M, Rossor AM, Laura M, Reilly MM. Next-generation sequencing in Charcot-Marie-Tooth disease: opportunities and challenges. Nat Rev Neurol. 2019;15:644–56. in press. doi:10.1038/s41582-019-0254-5.
  • Duggett NA, Griffiths LA, Flatters SJL. Paclitaxel-induced painful neuropathy is associated with changes in mitochondrial bioenergetics, glycolysis, and an energy deficit in dorsal root ganglia neurons. Pain. 2017;158(8):1499–508. doi:10.1097/j.pain.0000000000000939.
  • Gdynia HJ, Sperfeld AD, Knirsch U, Homberg, V, Rosenbohm, A, Muller-Hocker, J, Ludolph, AC, Hanemann, CO. Benign symmetric lipomatosis with axonal neuropathy and abnormalities in specific mitochondrial tRNA regions. Eur J Med Res. 2006;11(12):545–46.
  • Rantamaki MT, Soini HK, Finnila SM, Majamaa K, Udd B. Adult-onset ataxia and polyneuropathy caused by mitochondrial 8993T–>C mutation. Ann Neurol. 2005;58(2):337–40. doi:10.1002/ana.20555.
  • Pineda M, Solano A, Artuch R, Andreu, AL, Playan, A, Vilaseca, MA, Colomer, J, Briones, P, Casademont, J, et al. Peripheral neuropathy with ataxia in childhood as a result of the G8363A mutation in mitochondrial DNA. Pediatr Res. 2004;56(1):55–59. doi:10.1203/01.PDR.0000130475.20571.98.
  • Wang W, Wang C, Dawson DB, Thorland, EC, Lundquist, PA, Eckloff, BW, Wu, Y, Baheti, S, Evans, JM, Scherer, SS, et al. Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy. Neurology. 2016;86(19):1762–71. doi:10.1212/WNL.0000000000002659.
  • Hamosh A, Scott AF, Amberger J, Bocchini C, Valle D, McKusick VA. Online mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2002;30(1):52–55. doi:10.1093/nar/30.1.52.
  • de Beer TA, Laskowski RA, Parks SL, Sipos B, Goldman N, Thornton JM. Amino acid changes in disease-associated variants differ radically from variants observed in the 1000 genomes project dataset. PLoS Comput Biol. 2013;9(12):e1003382. doi:10.1371/journal.pcbi.1003382.
  • Richards S, Aziz N, Bale S, Bick, D, Das, S, Gastier-Foster, J, Grody, WW, Hegde, M, Lyon, E, Spector, E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24. doi:10.1038/gim.2015.30.
  • Politi C, Ciccacci C, D’Amato C, Novelli G, Borgiani P, Spallone V. Recent advances in exploring the genetic susceptibility to diabetic neuropathy. Diabetes Res Clin Pract. 2016;120:198–208. doi:10.1016/j.diabres.2016.08.006.
  • Snahnicanova Z, Mendelova A, Grendar M, Holubekova, V, Kostkova, M, Pozorciakova, K, Jancinová, M, Kasubova, I, Vojtkova, J, Durdik, P, et al. Association of polymorphisms in CYBA, SOD1, and CAT genes with Type 1 diabetes and diabetic peripheral neuropathy in children and adolescents. Genet Test Mol Biomarkers. 2018;22(7):413–19. doi:10.1089/gtmb.2018.0018.
  • Reyes-Gibby CC, Wang J, Yeung S-CJ, Shete S. Informative gene network for chemotherapy-induced peripheral neuropathy. BioData Min. 2015;8:24–24. doi:10.1186/s13040-015-0058-0.
  • Stüve O, Vernino S. The major histocompatibility complex and antibody-mediated limbic encephalitis. Ann Neurol. 2017;81(2):181–82. doi:10.1002/ana.24861.
  • Thawani SP, Brannagan TH III, Lebwohl B, Green PH, Ludvigsson JF. Risk of neuropathy among 28232 patients with biopsy-verified celiac disease. JAMA.Neurol. 2015;72:806. doi:10.1001/jamaneurol.2015.0475.
  • Treon SP, Xu L, Yang G, Zhou, Y, Liu, X, Cao, Y, Sheehy, P, Manning, RJ, Patterson, CJ, Tripsas, C, et al. MYD88 L265P somatic mutation in Waldenström’s macroglobulinemia. N Engl J Med. 2012;367(9):826–33. doi:10.1056/NEJMoa1200710.
  • Liu Y, Magro C, Loewenstein JI, Makar, RS, Stowell, CP, Dzik, WH, Hochberg, EP, Oaklander, AL, et al. A man with paraneoplastic retinopathy plus small fiber polyneuropathy associated with Waldenström macroglobulinemia (lymphoplasmacytic lymphoma): insights into mechanisms. Ocul Immunol Inflamm. 2015;23(5):405–09. doi:10.3109/09273948.2014.884599.
  • Klein CJ, Moon JS, Mauermann ML, Zeldenrust, SR, Wu, Y, Dispenzieri, A, Dyck, PJ. The neuropathies of Waldenström’s macroglobulinemia (WM) and IgM-MGUS. Can J Neurol Sci. 2011;38(2):289–95. doi:10.1017/S0317167100011483.
  • Chen FY, Lee A, Ge S, Nathan S, Knox SM, McNamara NA. Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjogren’s syndrome. PLoS One. 2017;12(9):e0184916. doi:10.1371/journal.pone.0184916.
  • Akin EJ, Higerd GP, Mis MA, Tanaka, BS, Adi, T, Liu, S, Dib-Hajj, FB, Waxman, SG, et al. Building sensory axons: delivery and distribution of NaV1.7 channels and effects of inflammatory mediators. Sci Adv. 2019;5(10):eaax4755. doi:10.1126/sciadv.aax4755.
  • Lunemann JD, Nimmerjahn F, Dalakas MC. Intravenous immunoglobulin in neurology–mode of action and clinical efficacy. Nat Rev Neurol. 2015;11(2):80–89. doi:10.1038/nrneurol.2014.253.
  • Oaklander AL, Lunn MP, Hughes RA, van Schaik IN, Frost C, Chalk CH. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews. Cochrane Database Syst Rev. 2017;1:CD010369.
  • Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev. 2014;19:CD002063.
  • Kuwabara S, Misawa S, Mori M, Iwai, Y, Ochi, K, Suzuki, H, Nodera, H, Tamaoka, A, Iijima, M, Toda, T, et al. Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: a multi-center, open-label, 52-week phase 3 trial. J Peripher Nerv Syst. 2018;23(2):115–19. doi:10.1111/jns.12268.
  • International Multiple Sclerosis Genetics C, Bush WS, Sawcer SJ, et al. Evidence for polygenic susceptibility to multiple sclerosis–the shape of things to come. Am J Hum Genet. 2010;86(4):621–25. doi:10.1016/j.ajhg.2010.02.027.